{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:24:18Z","timestamp":1789133058375,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009698","name":"Hawassa University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009698","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jviromet.2020.114057","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T17:47:33Z","timestamp":1609264053000},"page":"114057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Validity of a point-of-care viral load test for hepatitis B in a low-income setting"],"prefix":"10.1016","volume":"289","author":[{"given":"Gezahegn Mekonnen","family":"Woldemedihn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina Silvia","family":"Rueegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailemichael","family":"Desalegn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8757-3482","authenticated-orcid":false,"given":"Hanna","family":"Aberra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nega","family":"Berhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5966-7166","authenticated-orcid":false,"given":"Asgeir","family":"Johannessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2020.114057_bib0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12879-017-2549-8","article-title":"Early experiences from one of the first treatment programs for chronic hepatitis B in sub-Saharan Africa","volume":"17","author":"Aberra","year":"2017","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"10.1016\/j.jviromet.2020.114057_bib0010","doi-asserted-by":"crossref","first-page":"114946","DOI":"10.1016\/j.diagmicrobio.2019.114946","article-title":"Performance of the Xpert HBV Viral Load assay versus the Aptima Quant assay for quantifying hepatitis B virus DNA","volume":"96","author":"Abravanel","year":"2020","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.jviromet.2020.114057_bib0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/096228029900800204","article-title":"Measuring agreement in method comparison studies","volume":"8","author":"Bland","year":"1999","journal-title":"Stat. Methods Med. Res."},{"issue":"9","key":"10.1016\/j.jviromet.2020.114057_bib0020","doi-asserted-by":"crossref","first-page":"e44930","DOI":"10.1371\/journal.pone.0044930","article-title":"Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis","volume":"7","author":"Chon","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jviromet.2020.114057_bib0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12916-018-1229-x","article-title":"Treatment of chronic hepatitis B in sub-Saharan Africa: 1-year results of a pilot program in Ethiopia","volume":"16","author":"Desalegn","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/j.jviromet.2020.114057_bib0030","first-page":"372","article-title":"Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"EASL","year":"2017","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.jviromet.2020.114057_bib0035","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/bimj.200410135","article-title":"Estimation of the youden index and its associated cutoff point","volume":"47","author":"Fluss","year":"2005","journal-title":"Biom. J."},{"issue":"6","key":"10.1016\/j.jviromet.2020.114057_bib0040","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/jmv.24437","article-title":"Molecular epidemiology and genetic diversity of hepatitis B virus in Ethiopia","volume":"88","author":"Hundie","year":"2016","journal-title":"J. Med. Virol."},{"issue":"20","key":"10.1016\/j.jviromet.2020.114057_bib0045","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1002\/cncr.29537","article-title":"Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B","volume":"121","author":"Kim","year":"2015","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.jviromet.2020.114057_bib0050","doi-asserted-by":"crossref","first-page":"e559","DOI":"10.1016\/S2214-109X(16)30130-9","article-title":"Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in the Gambia: the prevention of liver fibrosis and cancer in Africa (PROLIFICA) study","volume":"4","author":"Lemoine","year":"2016","journal-title":"Lancet Glob. Health"},{"issue":"8","key":"10.1016\/j.jviromet.2020.114057_bib0055","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/gutjnl-2015-309260","article-title":"The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa","volume":"65","author":"Lemoine","year":"2016","journal-title":"Gut."},{"issue":"15","key":"10.1016\/j.jviromet.2020.114057_bib0060","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","article-title":"Lamivudine for patients with chronic hepatitis B and advanced liver disease","volume":"351","author":"Liaw","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"9865","key":"10.1016\/j.jviromet.2020.114057_bib0065","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2020.114057_bib0070","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12879-015-0881-4","article-title":"Short-term spontaneous fluctuations of HBV DNA levels in a Senegalese population with chronic hepatitis B","volume":"15","author":"Maylin","year":"2015","journal-title":"BMC Infect. Dis."},{"issue":"8","key":"10.1016\/j.jviromet.2020.114057_bib0075","doi-asserted-by":"crossref","first-page":"e568","DOI":"10.1016\/S2214-109X(16)30101-2","article-title":"Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in the Gambia: an economic modelling analysis","volume":"4","author":"Nayagam","year":"2016","journal-title":"Lancet Glob. Health"},{"issue":"11","key":"10.1016\/j.jviromet.2020.114057_bib0080","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.cmi.2019.03.021","article-title":"The rapid molecular test Xpert MTB\/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection","volume":"25","author":"Opota","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"issue":"6","key":"10.1016\/j.jviromet.2020.114057_bib0085","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2893.2007.00957.x","article-title":"Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection","volume":"15","author":"Papatheodoridis","year":"2008","journal-title":"J. Viral Hepat."},{"issue":"4","key":"10.1016\/j.jviromet.2020.114057_bib0090","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/bimj.200410133","article-title":"The youden index and the optimal cut-point corrected for measurement error","volume":"47","author":"Perkins","year":"2005","journal-title":"Biom. J."},{"issue":"1","key":"10.1016\/j.jviromet.2020.114057_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol. Int."},{"issue":"2","key":"10.1016\/j.jviromet.2020.114057_bib0100","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jhep.2009.11.007","article-title":"Efficacy of entecavir in treatment-na\u00efve patients with hepatitis B virus-related decompensated cirrhosis","volume":"52","author":"Shim","year":"2010","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.jviromet.2020.114057_bib0105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2020.114057_bib0110","series-title":"Guidelines for the Prevention, Care and Treatment of Persons With Chronic Hepatitis B Infection","author":"WHO","year":"2015"},{"key":"10.1016\/j.jviromet.2020.114057_bib0115","series-title":"Global Health Sector Strategy on Viral Hepatitis 2016-2021. Towards Ending Viral Hepatitis","first-page":"53","author":"WHO","year":"2016"},{"key":"10.1016\/j.jviromet.2020.114057_bib0120","series-title":"Global Hepatitis Report","first-page":"2017","author":"WHO","year":"2017"},{"key":"10.1016\/j.jviromet.2020.114057_bib0125","series-title":"Global Tuberculosis Report","first-page":"2019","author":"WHO","year":"2019"},{"key":"10.1016\/j.jviromet.2020.114057_bib0130","series-title":"Statistical Methods in Diagnostic Medicine","first-page":"1","author":"Zhou","year":"2011"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093420303098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093420303098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:53:32Z","timestamp":1759056812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093420303098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":26,"alternative-id":["S0166093420303098"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2020.114057","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validity of a point-of-care viral load test for hepatitis B in a low-income setting","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2020.114057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114057"}}